0001599298-24-000058.txt : 20240404 0001599298-24-000058.hdr.sgml : 20240404 20240404174715 ACCESSION NUMBER: 0001599298-24-000058 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240402 FILED AS OF DATE: 20240404 DATE AS OF CHANGE: 20240404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Anand Bhaskar CENTRAL INDEX KEY: 0001890784 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36866 FILM NUMBER: 24824205 MAIL ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Summit Therapeutics Inc. CENTRAL INDEX KEY: 0001599298 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2882 SAND HILL ROAD STREET 2: SUITE 106 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-460-8308 MAIL ADDRESS: STREET 1: 2882 SAND HILL ROAD STREET 2: SUITE 106 CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: Summit Therapeutics plc DATE OF NAME CHANGE: 20150219 FORMER COMPANY: FORMER CONFORMED NAME: Summit Corp plc DATE OF NAME CHANGE: 20140205 4 1 wk-form4_1712267219.xml FORM 4 X0508 4 2024-04-02 0 0001599298 Summit Therapeutics Inc. SMMT 0001890784 Anand Bhaskar C/O SUMMIT THERAPEUTICS INC. 601 BRICKELL KEY DRIVE, SUITE 1000 MIAMI FL 33131 0 1 0 0 Chief Accounting Officer 0 Stock Option (right to buy) 3.85 2024-04-02 4 A 0 600000 A 2034-04-02 Common Stock 600000 600000 D The option was granted on April 2, 2024. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on April 2, 2025. Note this does not include an additional 600,000 options which were granted on April 2, 2024 and are subject to the satisfaction of performance conditions based on market capitalization and revenue targets. Not applicable. /s/ Bhaskar Anand 2024-04-04